Symbiosis Pharma specialise in biologics contract manufacturing and biologics filling. If you are responsible for the development of a biopharmaceutical drug product, then your project may require an outsourced partner that can convert your precious biological drug substance into a sterile final drug product.
Given Symbiosis’ experience in supporting multiple clients from around Europe and the US who have this specific challenge, we believe we are perfectly placed to successfully deliver on the sterile fill finish for biologics.
Clean Room Facilities
Operating within dedicated cleanroom facilities at our GMP MHRA-licensed facility in Europe, our experienced team routinely fill biological pharmaceutical products such as:
- Antibody-Drug Conjugates (ADCs)
- Cytotoxic, cytostatic and highly potent APIs
Our small-scale capability enables us to fill bulk volumes under 100 liters per batch, including products that require aseptic liquid filling and specialist lyophilization. Our biologics contract manufacturing capability can accommodate drug product supply requirements for clinical trials and low volume commercial supply into Europe or the US.
Due to the complex nature of sterile manufacturing of biological drug products, quality, regulatory compliance, and the highest levels of technical capability are at the heart of the service we provide for every project we undertake.
As an agile CMO, we are also flexible in terms of offering our biotech and specialty pharmaceutical clients rapid access to manufacturing slots, fast QA batch release and a quicker route to clinic.
If you are planning a biological sterile manufacturing project, or want to find out more about our biologics contract manufacturing services, then please contact our team today. If your deadline is tight, then ask our team about available manufacturing slots.